Or, are you sure this wasn’t written by ChatGPT?
Utilizing social listening data to understand patterns and trends in patient behaviors can now make that journey easier, improve quality of life and result in better outcomes for patients.
Achieving equity in the healthcare setting means going beyond the cost-of-entry phrase, “I see you.” To make meaningful change, we must truthfully say, “I understand you.”
For pharma companies, health equity isn’t something that can be provided as much as enabled. This may seem like mincing words, but this small shift in the way we think about working toward health equity can help point brands in the right direction.
Many things have changed in brand representation over the course of the past few years and these changes will continue to accelerate as we move forward. What hasn’t changed is the necessity to provide HCPs with the information and support on which to base adoption, and to do so with the personalization required to build relationships over time.
2023 promises to be yet another year of uncertainty for marketers in general, but what about healthcare marketers?
Did we miss something that will have a major impact on pharma marketing this year? We asked our respondents to write their own questions and answer them.
Life sciences and pharmaceutical brands understand that increased commercial performance and growth are only possible through optimized customer engagement and satisfaction.
Insights from CMI Media Group’s Media Vitals Research, specially prepared for MedAdNews
As we settle ourselves into 2023, this transition continues. Pharma marketers should prepare for a period of recalibration, transparency, and connection.